Reply to thread

Message: [QUOTE="Da_Aisijimo_Gou, post: 3830144, member: 264"] CYDY - possible pending corporate action, could be potential Nasdaq listing. Or, unblinding of US FDA Phase 3 trial results for Leronlimab (Vyrologix brand) severe to critical COVID19 patient treatment. If the US eventually gives Vyrologix emergency authorization (EUA), it will potentially be huge for S/C patients, then maybe SARS2 long haulers. Maybe even other viruses and diseases. After GME and guilt at receiving an unnecessary stimulus credit prompted buying a month’s groceries for several families, CYDY may save lives and help feed more struggling families. Hope so as a vaccine complement to limit COVID’s societal impacts, and to possibly help enable normal-er lifestyles. [/QUOTE]